{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:28:46Z","timestamp":1779312526050,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pep.2018.01.014","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T09:37:24Z","timestamp":1517477844000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["High level expression and immunochemical characterization of botulinum neurotoxin type F light chain"],"prefix":"10.1016","volume":"146","author":[{"given":"Ritika","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinita","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mula Kameshwar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Bhagyawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Kumar","family":"Dhaked","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2018.01.014_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pep.2018.01.014_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0041-0101(01)00157-X","article-title":"Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective","volume":"39","author":"Johnson","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.pep.2018.01.014_bib3","series-title":"Botulism: the Organism, its Toxins","author":"Smith","year":"1988"},{"key":"10.1016\/j.pep.2018.01.014_bib4","first-page":"680","article-title":"Botulism outbreak associated with eating fermented food- Alaska 2001","volume":"50","author":"CDC (Centers for Disease Control)","year":"2001","journal-title":"MMWR"},{"key":"10.1016\/j.pep.2018.01.014_bib5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pep.2018.01.014_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A Novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pep.2018.01.014_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/infdis\/jiv327","article-title":"A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin","volume":"213","author":"Susan","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pep.2018.01.014_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X2005000100035","article-title":"Botulinum toxin, Mechanisms of action","volume":"63","author":"Dressler","year":"2005","journal-title":"Arq. Neuro-psiquiatr"},{"key":"10.1016\/j.pep.2018.01.014_bib9","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"Smith","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pep.2018.01.014_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1348-0421.1995.tb02184.x","article-title":"Structure and function of Clostridium botulinum toxins","volume":"39","author":"Oguma","year":"1995","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.pep.2018.01.014_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pep.2018.01.014_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin","volume":"69","author":"Black","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pep.2018.01.014_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa051926","article-title":"Human botulism immune globulin for the treatment of infant botulism","volume":"354","author":"Arnon","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pep.2018.01.014_bib14","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1128\/jcm.26.11.2351-2356.1988","article-title":"Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay","volume":"26","author":"Siegel","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.pep.2018.01.014_bib15","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.4049\/jimmunol.174.4.2190","article-title":"A novel neurotoxoid vaccine prevents mucosal botulism","volume":"174","author":"Kobayashi","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.pep.2018.01.014_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2003.08.112","article-title":"Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity","volume":"310","author":"Burnett","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pep.2018.01.014_bib17","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1371\/journal.pone.0007730","article-title":"Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidases developed by synthesis-based computer-aided molecular design","volume":"4","author":"Pang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pep.2018.01.014_bib18","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.bmc.2009.03.013","article-title":"Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs","volume":"17","author":"Moe","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib19","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.bmc.2006.01.015","article-title":"Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A","volume":"14","author":"Merino","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib20","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00141-09","article-title":"Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A","volume":"53","author":"Roxas-Duncan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pep.2018.01.014_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/ol0603211","article-title":"Identification of a potent botulinum neurotoxin toxin a protease inhibitor using in situ lead identification chemistry","volume":"8","author":"Boldt","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.pep.2018.01.014_bib22","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1039\/C5CC00677E","article-title":"Toward the discovery of dual inhibitors for botulinum neurotoxin A: concomitant targeting of endocytosis and light chain protease activity","volume":"51","author":"Seki","year":"2015","journal-title":"Chem. Comm"},{"key":"10.1016\/j.pep.2018.01.014_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/acs.jmedchem.6b01393","article-title":"Newly designed quinolinol inhibitors mitigate the effects of botulinum neurotoxin A in enzymatic, cell-based, and ex vivo assays","volume":"60","author":"Bremer","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0014-5793(98)00492-X","article-title":"Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity","volume":"429","author":"Adler","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pep.2018.01.014_bib25","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/S0968-0896(03)00450-4","article-title":"Thio-derived disulfides as potent inhibitors of botulinum neurotoxin type B: implications for zinc interaction","volume":"11","author":"Anne","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib26","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1021\/jm0300680","article-title":"Development of potent inhibitors of botulinum neurotoxin type B","volume":"46","author":"Anne","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1107\/S0907444901013531","article-title":"Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B","volume":"57","author":"Eswaramoorthy","year":"2001","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1016\/j.pep.2018.01.014_bib28","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1039\/c2cc17158a","article-title":"Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening","volume":"48","author":"Kumar","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.pep.2018.01.014_bib29","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1016\/j.bmc.2016.06.036","article-title":"Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: structure\u2013activity relationship and a pharmacophore model","volume":"24","author":"Kumar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.pep.2018.01.014_bib30","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.bmc.2016.07.031","article-title":"Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity","volume":"24","author":"Zhou","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxicon.2015.02.012","article-title":"Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors","volume":"48","author":"Montgomery","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.pep.2018.01.014_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/molecules16010202","article-title":"Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication","volume":"16","author":"Li","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.pep.2018.01.014_bib33","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1021\/bi0510072","article-title":"Structural analysis of botulinum neurotoxin serotype F light chain:\u2009 Implications on substrate binding and inhibitor design","volume":"44","author":"Agarwal","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.pep.2018.01.014_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pep.2015.01.014","article-title":"Expression and biochemical characterization of light chains of botulinum neurotoxin subtypes F5 and F7","volume":"111","author":"Guo","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2018.01.014_bib35","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1073\/pnas.97.17.9695","article-title":"Ca2+-dependent regulation of synaptic SNARE complex assembly via a calmodulin- and phospholipid-binding domain of synaptobrevin","volume":"97","author":"Quetglas","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.pep.2018.01.014_bib36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/092986611797642689","article-title":"Prevention of aggregation and autocatalysis for sustaining biological activity of recombinant BoNT\/A-LC upon long-term storage","volume":"18","author":"Singh","year":"2011","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.pep.2018.01.014_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1026549431380","article-title":"Light chain of botulinum A neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active","volume":"19","author":"Ahmed","year":"2000","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.pep.2018.01.014_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pep.2005.09.024","article-title":"Expression, purification, and characterization of Clostridium botulinum type B light chain","volume":"46","author":"Gilsdorf","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2018.01.014_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pep.2003.10.017","article-title":"Cloning, high level expression, purification and crystallization of the full length Clostridium botulinum neurotoxin type E light chain","volume":"34","author":"Agarwal","year":"2004","journal-title":"Protein Expr. Purif."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592817307271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592817307271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:51:42Z","timestamp":1760925102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592817307271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":39,"alternative-id":["S1046592817307271"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2018.01.014","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High level expression and immunochemical characterization of botulinum neurotoxin type F light chain","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2018.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}